Literature DB >> 11036006

Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution.

P M Loiseau1, P Lubert, J G Wolf.   

Abstract

Twelve new dithiaarsanes were evaluated for their in vitro and in vivo trypanocidal properties in regard to their three parent molecules, 4-amino-phenylarsenoxide, melarsenoxide, and 4-dansylamino-phenylarsenoxide. The most potent dithiaarsane, compound 2b, had a minimum effective concentration of 1.5 nM after 48 h of incubation and at a dose of 0.39 micromol/kg of body weight (0.2 mg/kg) administered subcutaneously cured 100% of mice acutely infected with Trypanosoma brucei brucei CMP. With this model, the chemotherapeutic index of compound 2b was 512, compared to 256 for melarsamine dihydrochloride (Cymelarsan) under the same conditions. With a chronic infection produced by T. brucei brucei GVR, compound 2b cured 100% of mice after treatment at a dose of 25 micromol/kg (12.5 mg/kg) for 4 consecutive days, whereas melarsamine dihydrochloride and potassium melarsonyl (Trimelarsan) cured less than 50% mice at this dose. For both acute and late-stage infections, dithiaarsanes having a melaminophenyl ring exhibited the most-potent trypanocidal activity. Compound 2b is thus one of the most active organoarsenicals described in a mouse trypanosomiasis model. Considering that the main intracellular targets of organoarsenicals are thiol groups, we studied the possibility of ligand exchange between Cymelarsan and several dithiols. In aqueous solution, we observed a rapid exchange of cysteamine from melarsamine with free cysteamine and also with various dithiols always in favor of more stable cyclic derivatives. These ligand exchanges suggest the ability of trivalent organoarsenicals to react with targets such as trypanothione and dihydrolipoic acid. Among several ligands, a 1,3-dimercaptopropane moiety appeared the most suitable for trypanocidal activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036006      PMCID: PMC101586          DOI: 10.1128/AAC.44.11.2954-2961.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.

Authors:  A G Scott; A Tait; C M Turner
Journal:  Exp Parasitol       Date:  1997-07       Impact factor: 2.011

2.  Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya.

Authors:  M Otsyula; K Kamar; M Mutugi; A R Njogu
Journal:  Acta Trop       Date:  1992-02       Impact factor: 3.112

3.  Mel B in the treatment of human trypanosomiasis.

Authors:  E A H FRIEDHEIM
Journal:  Am J Trop Med Hyg       Date:  1949-03       Impact factor: 2.345

4.  Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.

Authors:  J Pépin; F Milord; A N Khonde; T Niyonsenga; L Loko; B Mpia; P De Wals
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

5.  The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.

Authors:  F W Jennings; J M Atouguia; M Murray
Journal:  Acta Trop       Date:  1996-10       Impact factor: 3.112

6.  Synthesis and in vitro anthelmintic properties of some new dithiaarsanes.

Authors:  P M Loiseau; P Lubert; J G Wolf
Journal:  Arzneimittelforschung       Date:  1999-11

7.  Trypanothione is the primary target for arsenical drugs against African trypanosomes.

Authors:  A H Fairlamb; G B Henderson; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution.

Authors:  B J Berger; A H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Preliminary observations on the efficacy of mel Cy (Cymelarsan) in domestic animals infected with stocks of Trypanosoma brucei brucei and T.b. evansi.

Authors:  E Zweygarth; J Ngeranwa; R Kaminsky
Journal:  Trop Med Parasitol       Date:  1992-12

10.  The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.

Authors:  A H Fairlamb; K Smith; K J Hunter
Journal:  Mol Biochem Parasitol       Date:  1992-07       Impact factor: 1.759

View more
  3 in total

1.  Antiprotozoal activity of ferroquine.

Authors:  S Pomel; C Biot; C Bories; P M Loiseau
Journal:  Parasitol Res       Date:  2012-11-15       Impact factor: 2.289

2.  An improved synthesis of arsenic-biotin conjugates.

Authors:  Jorge Heredia-Moya; Kenneth L Kirk
Journal:  Bioorg Med Chem       Date:  2008-03-27       Impact factor: 3.641

3.  Development of a red fluorescent light-up probe for highly selective and sensitive detection of vicinal dithiol-containing proteins in living cells.

Authors:  Yuanyuan Wang; Xiao-Feng Yang; Yaogang Zhong; Xueyun Gong; Zheng Li; Hua Li
Journal:  Chem Sci       Date:  2015-10-23       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.